Central Pacific Bank - Trust Division’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
CWP
Central Pacific Bank - Trust Division's PFE Position: Q2 2026 in Review
Central Pacific Bank - Trust Division increased its Pfizer (PFE) stake by 3.4% in Q2 2026, buying an estimated $19.8K and bringing the position to 23,301 shares worth $561K. The position accounts for 0.06% of the portfolio, ranked #301.
Central Pacific Bank - Trust Division first reported a position in PFE in Q1 2024 and has held it in 10 quarters since. The position peaked at $633K in Q1 2026. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Central Pacific Bank - Trust Division held 23,301 shares of Pfizer worth $561K as of Q2 2026.
- Central Pacific Bank - Trust Division bought 756 Pfizer shares in Q2 2026, an estimated $19.8K.
- Pfizer made up 0.06% of Central Pacific Bank - Trust Division's portfolio in Q2 2026, its #301 holding.
- Central Pacific Bank - Trust Division first reported a position in Pfizer in Q1 2024 and has held it in 10 quarters since.
- Central Pacific Bank - Trust Division's Pfizer position peaked at $633K in Q1 2026.
- 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Central Pacific Bank - Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.